About: Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report from a Multicenter New York Area Institution

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report from a Multicenter New York Area Institution Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report from a Multicenter New York Area Institution
Creator	Adair, Nilda Chen, William Fastro, M Ocn, R Potters, Louis Rtt, Nilda Somerstein, Gayle Teckie, Sewit
source	Elsevier; Medline; PMC
abstract	As the COVID-19 pandemic spreads around the globe, access to radiation therapy remains critical for cancer patients. The priority for all radiation oncology departments is to protect the staff and to maintain operations in providing access to those patients requiring radiation therapy services. Patients with tumors of the aerodigestive tract and pelvis amongst others often experience toxicity during treatment, and there is a baseline risk that adverse effects may require hospital-based management. Routine care during weekly visits is important to guide patients through treatment and to mitigate against the need for hospitalization. Nevertheless, hospitalizations occur and there is a risk of nosocomial SARS-CoV-2 spread. During the COVID-19 pandemic, typical resources used to help manage patients, such as dental services, interventional radiology, rehabilitation and others are limited or not at all available. Recognizing the need to provide access to treatment and the anticipated toxicity of such treatment, we have developed and implemented guidelines for clinical care management with the hope of avoiding added risk to our patients. If successful, these concepts may be integrated into our care directives in non-pandemic times.
has issue date	2020-05-11(xsd:dateTime)
bibo:doi	10.1016/j.adro.2020.04.021
bibo:pmid	32395672
has license	no-cc
sha1sum (hex)	4235b9a8fa6963907aba8a83b9c354c943716197
schema:url	https://doi.org/10.1016/j.adro.2020.04.021
resource representing a document's title	Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report from a Multicenter New York Area Institution
has PubMed Central identifier	PMC7212958
has PubMed identifier	32395672
schema:publication	Adv Radiat Oncol
resource representing a document's body	covid:4235b9a8fa6963907aba8a83b9c354c943716197#body_text
is schema:about of	named entity 'avoid' named entity 'Reduce' named entity 'Area' named entity 'Reduce' named entity 'Institution' named entity 'HOSPITALIZATION' named entity 'During' named entity 'care' named entity 'Institution' named entity 'Area' named entity 'clinical care' named entity 'COVID-19 pandemic' named entity 'clinical care' named entity 'Multicenter' named entity 'outpatient' named entity 'COVID' named entity 'morbidity' named entity 'palliative treatments' named entity 'clinical care' named entity 'radiotherapy' named entity 'radiation treatments' named entity 'prognosis' named entity 'COVID' named entity 'emergency department' named entity 'emergency department' named entity 'chemotherapy' named entity 'lung' named entity 'betacoronavirus' named entity 'New York City' named entity 'chemotherapy' named entity 'radiation therapy' named entity 'outpatient centers' named entity 'COVID' named entity 'clinical practice' named entity 'esophageal dilation' named entity 'clinical guidelines' named entity 'infection' named entity 'COVID-19 pandemic' named entity 'infection' named entity 'intensive care unit' named entity 'chemotherapy' named entity 'Suffolk' named entity 'quality assurance program' named entity 'gynecologic' named entity 'anesthesia' named entity 'head-and-neck cancer' named entity 'World Health Organization' named entity 'Wuhan City' named entity 'labor and delivery' named entity 'Asia' named entity 'radiation therapy' named entity 'RNA' named entity 'care providers' named entity 'peer-reviewed' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'emergency department' named entity 'global COVID-19 pandemic' named entity 'pathology' named entity 'New York' named entity 'SARS-CoV-2' named entity 'care providers' named entity 'morbidity' named entity 'acute hospital' named entity 'York region' named entity 'rates of infection' named entity 'cancer treatments' named entity 'physical therapy' named entity 'inpatient admissions' named entity 'China' named entity 'health care' named entity 'infusion services' named entity 'Radiation oncologists' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software